CTMX

CytomX Therapeutics (CTMX)

CytomX Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CTMX

<< 前へ 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2018/09/07	08 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/08/09	05 : 14	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/08/09	05 : 06	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/08/09	05 : 04	GlobeNewswire Inc.	CytomX Therapeutics Announces Second Quarter 2018 Financial Results	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/08/08	05 : 01	GlobeNewswire Inc.	CytomX to Present at the 2018 Wedbush PacGrow Healthcare Conference	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/07/31	05 : 01	GlobeNewswire Inc.	CytomX Therapeutics to Announce Second Quarter 2018 Financial Results	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/07/18	05 : 12	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/07/18	05 : 01	GlobeNewswire Inc.	CytomX Therapeutics Announces Closing of Public Offering of Common Stock	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/07/14	06 : 16	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/07/13	08 : 50	GlobeNewswire Inc.	CytomX Therapeutics Announces Pricing of Public Offering of Common Stock	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/07/11	05 : 11	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/07/11	05 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/07/11	05 : 01	GlobeNewswire Inc.	CytomX Therapeutics Announces Proposed Public Offering of Common Stock	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/07/10	07 : 21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/07/07	07 : 54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/07/04	07 : 52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/07/04	07 : 52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/06/16	06 : 53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/06/16	06 : 53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/06/16	06 : 52	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/06/16	06 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/06/16	06 : 48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/06/16	06 : 48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/06/16	05 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/06/14	20 : 30	GlobeNewswire Inc.	CytomX Announces Appointment of Lloyd A. Rowland Jr. as General Counsel	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/06/06	08 : 47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/06/06	08 : 46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/06/04	22 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/06/04	22 : 00	GlobeNewswire Inc.	CytomX Therapeutics Presents Preliminary Clinical Proof-of-Concept Data from Probody™ Platform and CX-072 at 2018 ASCO Annu...	NASDAQ:CTMX	CytomX Therapeutics Inc
2018/06/01	20 : 30	GlobeNewswire Inc.	CytomX Announces Conference Call and Webcast to Review PROCLAIM-072 Clinical Data Presentations at the 2018 American Society ...	NASDAQ:CTMX	CytomX Therapeutics Inc